247 related articles for article (PubMed ID: 17236969)
1. Ototoxicity after radiotherapy for head and neck tumors.
Bhandare N; Antonelli PJ; Morris CG; Malayapa RS; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):469-79. PubMed ID: 17236969
[TBL] [Abstract][Full Text] [Related]
2. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Hitchcock YJ; Tward JD; Szabo A; Bentz BG; Shrieve DC
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):779-88. PubMed ID: 18707819
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
Pan CC; Eisbruch A; Lee JS; Snorrason RM; Ten Haken RK; Kileny PR
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1393-402. PubMed ID: 15817342
[TBL] [Abstract][Full Text] [Related]
4. Hypopituitarism after radiotherapy for extracranial head and neck cancers in pediatric patients.
Bhandare N; Kennedy L; Malyapa RS; Morris CG; Mendenhall WM
Am J Clin Oncol; 2008 Dec; 31(6):567-72. PubMed ID: 19060589
[TBL] [Abstract][Full Text] [Related]
5. Preventing radiation retinopathy with hyperfractionation.
Monroe AT; Bhandare N; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):856-64. PubMed ID: 15708266
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.
Zuur CL; Simis YJ; Lamers EA; Hart AA; Dreschler WA; Balm AJ; Rasch CR
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):490-6. PubMed ID: 19135315
[TBL] [Abstract][Full Text] [Related]
7. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
[TBL] [Abstract][Full Text] [Related]
8. Primary and central hypothyroidism after radiotherapy for head-and-neck tumors.
Bhandare N; Kennedy L; Malyapa RS; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1131-9. PubMed ID: 17446000
[TBL] [Abstract][Full Text] [Related]
9. A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan.
Wada H; Nemoto K; Ogawa Y; Hareyama M; Yoshida H; Takamura A; Ohmori K; Hamamoto Y; Sugita T; Saitoh M; Yamada S
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):495-500. PubMed ID: 15145168
[TBL] [Abstract][Full Text] [Related]
10. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Rasch CR; Schornagel JH; Dreschler WA; Balm AJ
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1320-5. PubMed ID: 17418969
[TBL] [Abstract][Full Text] [Related]
11. Hypopituitarism after radiotherapy for extracranial head and neck cancers.
Bhandare N; Kennedy L; Malyapa RS; Morris CG; Mendenhall WM
Head Neck; 2008 Sep; 30(9):1182-92. PubMed ID: 18446838
[TBL] [Abstract][Full Text] [Related]
12. [Damage to inner ear function caused by the effect of ionizing rays].
Strohm M; Ahlemann LM; Böhringer WK
HNO; 1985 Jan; 33(1):26-9. PubMed ID: 3972645
[TBL] [Abstract][Full Text] [Related]
13. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
14. Severe dry eye syndrome after radiotherapy for head-and-neck tumors.
Bhandare N; Moiseenko V; Song WY; Morris CG; Bhatti MT; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1501-8. PubMed ID: 21764525
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy-induced ear toxicity.
Jereczek-Fossa BA; Zarowski A; Milani F; Orecchia R
Cancer Treat Rev; 2003 Oct; 29(5):417-30. PubMed ID: 12972360
[TBL] [Abstract][Full Text] [Related]
16. Frequency of esophageal stenosis after simultaneous modulated accelerated radiation therapy and chemotherapy for head and neck cancer.
Lawson JD; Otto K; Grist W; Johnstone PA
Am J Otolaryngol; 2008; 29(1):13-9. PubMed ID: 18061826
[TBL] [Abstract][Full Text] [Related]
17. Effect of radiotherapy on retro-cochlear auditory pathways.
Low WK; Burgess R; Fong KW; Wang DY
Laryngoscope; 2005 Oct; 115(10):1823-6. PubMed ID: 16222203
[TBL] [Abstract][Full Text] [Related]
18. Does altered fractionation influence the risk of radiation-induced optic neuropathy?
Bhandare N; Monroe AT; Morris CG; Bhatti MT; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1070-7. PubMed ID: 15990010
[TBL] [Abstract][Full Text] [Related]
19. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
Lee AW; Ng WT; Hung WM; Choi CW; Tung R; Ling YH; Cheng PT; Yau TK; Chang AT; Leung SK; Lee MC; Bentzen SM
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1121-8. PubMed ID: 18723296
[TBL] [Abstract][Full Text] [Related]
20. A prospective study on radiation-induced changes in hearing function.
Herrmann F; Dörr W; Müller R; Herrmann T
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1338-44. PubMed ID: 16863923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
